{"schema_version":"secwatch.filing_event.v1","accession":"0001645666-25-000001","form_type":"8-K","ticker":"KZR","cik":"0001645666","company_name":"Kezar Life Sciences, Inc.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.291737+00:00","generated_at":"2026-05-28T05:07:14.723823+00:00","sec_items":["2.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Kezar Life Sciences reports preliminary cash of $132.2M as of Dec 31, 2024","bullets":["Preliminary cash, equivalents, and marketable securities at $132.2M as of December 31, 2024.","Shares outstanding of 7.3 million as of December 31, 2024.","Estimates are unaudited, subject to year-end closing adjustments; not a comprehensive financial statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001645666-25-000001","json":"https://secwatch.observer/filing/0001645666-25-000001.json","markdown":"https://secwatch.observer/filing/0001645666-25-000001.md","text":"https://secwatch.observer/filing/0001645666-25-000001.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645666/000164566625000001/0001645666-25-000001-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645666/000164566625000001/kzr-20250110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T05:07:14.723823+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}